PRESS RELEASE Montgomeryville, Pennsylvania, February 1, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has announced the appointment of John Costalas to its senior leadership team as Vice President of Construction. John joins AES after a successful 30-year design-build career in the life science industry. He brings a wealth of knowledge on … Continue reading "AES Clean Technology enhances cleanroom construction capabilities through new senior appointment."

PRESS RELEASE Montgomeryville, Pennsylvania, January 16, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO). With 18 years of experience, Brian is a proven leader in the cleanrooms and controlled environment industry. He joins AES from Controlled Contamination Services, where he spent ten years … Continue reading "AES Clean Technology expands senior leadership team with key appointment"

Cleanrooms are core pharmaceutical industry facilities that enable the effective manufacturing of sterile drug products (DPs) that bypass the human body’s natural defenses — such as those using the injectable or ophthalmic routes of delivery.

With Trista Hager, Vice President, Sales, AES Clean Technology As many therapeutics rely on a controlled environment to ensure their safety, selecting the right cleanroom vendor is critical. Impacting the speed at which therapeutic production can commence, your chosen cleanroom partner can heavily influence how quickly critical medicines can reach the patients who need them. … Continue reading "Top 10 questions when choosing a cleanroom partner: Part 2"

With Trista Hager, Vice President, Sales, AES Clean Technology The design, development and installation of a cleanroom are integral to the successful production of innovative therapeutics with the potential to change patients’ lives. The chosen cleanroom vendor can make or break the accelerated delivery of new medicines to patients, with therapeutics needing facilities with a … Continue reading "Top 10 questions when choosing a cleanroom partner: Part 1"

“A cleanroom project starts with a design concept that is centered around a biopharmaceutical manufacturer’s strategic goals. Ideally, a cross-functional team will work with the design firm following a structured process to develop a comprehensive compliant design that addresses the current needs while providing flexibility for future requirements. With its Compass™ Program, AES Clean Technology … Continue reading "AES Clean Technology Featured in Pharma's Almanac"

PRESS RELEASE Provider of high-performance cleanroom facilities for the pharmaceutical industry, AES Clean Technology, is celebrating two of its customers’ success at this year’s IPSE Facility of the Year Awards (FOYA), having designed and built the cleanrooms in both Genentech and Nexus Pharmaceuticals’ award-winning facilities. The ISPE FOYA awards celebrate state-of-the-art projects that use new, … Continue reading "AES Clean Technology’s clients double down on ISPE Facility of the Year Awards (FOYA)"

Can a modular approach to cleanroom technology deliver flexible sterile manufacturing capacity? Trista Hager, Vice President of Sales at AES Clean Technology, explores the challenges facing pharmaceutical manufacturers in expanding their cleanroom capacity to meet burgeoning market demand. She discusses how a modular approach to new cleanroom installation can help deliver the flexible sterile manufacturing … Continue reading "IPI Magazine September issue - Modular Cleanrooms"

Representing an integral component of drug development and manufacturing, cleanrooms must be carefully designed and constructed to meet unique project needs. This is no simple task. As well as the highly specific needs pharma and biopharma cleanrooms must deliver — including ventilation, plumbing, fire protection and electrical wiring — cleanrooms must also be designed to … Continue reading "BIM: Ensuring a solid foundation for cleanroom project execution"

Introduction We are in the midst of a next-generation scientific revolution in personalized therapeutic medicine, however, the design of manufacturing infrastructure continues to follow an outdated playbook. Current advances in cell, gene and tissue therapies require a rethinking of how—and where—cleanroom manufacturing facilities could be built enabling more options for sponsor process control. Cell, gene … Continue reading "Advanced Therapy Medicinal Product Cleanroom Facilities: A Roadmap for Success"